(Q40197211)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164782%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

title

Infected cell carriers: a new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164782%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164782%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

8

Stephen J Russell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164782%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

Ianko D Iankov

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164782%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Boris Blechacz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164782%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Chunsheng Liu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164782%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Jeffrey D Schmeckpeper

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164782%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

James E Tarara

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164782%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Mark J Federspiel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164782%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164782%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164782%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164782%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164782%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

114-122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164782%20AND%20SRC:MED&resulttype=core&format=json

Oncolytic viral therapies

23 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Oncolytic measles viruses for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Systemic therapy of myeloma xenografts by an attenuated measles virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Oncolytic measles virus in cutaneous T-cell lymphomas mounts antitumor immune responses in vivo and targets interferon-resistant tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Structure and function of a paramyxovirus fusion protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

The human CD46 molecule is a receptor for measles virus (Edmonston strain)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

SLAM (CDw150) is a cellular receptor for measles virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Measles virus-specific functional antibody responses and viremia during acute measles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Neutralizing B cell response in measles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Comparison of measles virus-specific antibodies with antibody-dependent cellular cytotoxicity and neutralizing functions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

In vitro reduction of virus infectivity by antibody-dependent cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Mechanism of injury of virus-infected cells by antiviral antibody and complement: participation of IgG, F(ab')2, and the alternative complement pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Role of CD8(+) lymphocytes in control and clearance of measles virus infection of rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Measles virus protein-specific IgM, IgA, and IgG subclass responses during the acute and convalescent phase of infection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Measles virus-specific immunoglobulin G isotype immune response in early and late infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Comparative analysis of titers of antibody against measles virus in sera of vaccinated and naturally infected Japanese individuals of different age groups

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Immunoglobulin G subclass profile of antimeasles response in vaccinated children and in adults with measles history

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Degree and length of viremia in adults with measles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Cell surface activation of the alternative complement pathway by the fusion protein of measles virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Antibody-independent activation of the alternative complement pathway by measles virus-infected cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Infection of monocytes during measles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Roles of macrophages in measles virus infection of genetically modified mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Biodistribution of Oncolytic Measles Virus After Intraperitoneal Administration into Ifnar™-CD46Ge Transgenic Mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Limited contribution of humoral immunity to the clearance of measles viremia in rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Pharmacokinetics of oncolytic measles virotherapy: eventual equilibrium between virus and tumor in an ovarian cancer xenograft model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Neutralisation of adenovirus infectivity by ascitic fluid from ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Interaction of measles virus vectors with Auger electron emitting radioisotopes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

In vitro and in vivo infection of neural cells by a recombinant measles virus expressing enhanced green fluorescent protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021

Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300020

7 January 2021